Massachusetts Financial Services CO Sorrento Therapeutics, Inc. Transaction History

Massachusetts Financial Services CO

  • $320 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021
SELL
$7.41 - $10.99 $199,869 - $296,433
-26,973 Closed
0 $0
Q2 2021

Aug 13, 2021
SELL
$6.35 - $10.0 $478,434 - $753,440
-75,344 Reduced 73.64%
26,973 $261,000
Q1 2021

May 13, 2021
SELL
$7.03 - $16.51 $758,761 - $1.78 Million
-107,932 Reduced 51.34%
102,317 $846,000
Q4 2020

Feb 12, 2021
BUY
$5.76 - $11.95 $1.21 Million - $2.51 Million
210,249 New
210,249 $1.44 Million

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email